04 and 05
/ NOV

LIVE FROM 8:00 AM

(UTC -3, SÃO PAULO, BRAZIL)

3rd International Symposium on Minimal Treatment and Breast Imaging

INTERNATIONAL SCIENTIFIC COMMITTEE

Stuart MacIntosh

Nisha Sharma

Ritse Mann

Joerg Heil

Alastair Thompson

Henrique Lima Couto

Fábio Postiglione Mansani

Gil Fascina

Francisco Pimentel Cavalcante

Vilmar Marques de Oliveira

Annamaria Massahud Rodrigues dos Santos

THE MAIN TOPICS ADDRESSED

SPEAKERS INTERNATIONAL GUESTS CONFIRMED

Alastair M. Thompson

ALCM, BSc(Hons), MBChB, MD, FRCSEd(Gen)

Joerg Heil

MD, PhD

Nisha Sharma

MBChB, BSB(Hons), MRCP, FRCR, MSC

Ritse Mann

MD, PhD

Stuart McIntosh

MD

MAKE YOUR REGISTRATION FREE EVENT FOR DOCTORS

RESIDENTS AND UNDERGRADUATES
UNTIL
06/30/2022
UNTIL
08/31/2022
UNTIL
10/31/2022
FROM
11/01/2022
DOCTOR

All Specialties

Free Free Free Free
RESIDENT AND
GRADUATE STUDENT
All Specialties
Free Free Free Free
UNDERGRADUATE
STUDENT
Free Free Free Free
OTHERS
PROFESSIONALS
R$ 450,00 R$ 500,00 R$ 550,00 R$ 600,00

COMING SOON SCIENTIFIC PROGRAM

PRELIMINARY PROGRAM - SUBJECT TO CHANGE SCIENTIFIC PROGRAM

08:00 - 08:05

OPENING

Lorem ipsum dolor sit (UF)


Lorem ipsum dolor sit (UF)


Lorem ipsum dolor sit (UF)

08:05 – 09:05

BREAST CANCER SCREENING – ROUND 01

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

08:05 – 08:10:
Presentation

08:10 - 08:25:
Personalized Imaging Screening x Tumoral Circulating Cells Screening – Is it the future?

Speaker: Lorem ipsum dolor sit (UF)

08:25 - 08:40:
Breast digital tomosynthesis screening. Is it time to change?

Speaker: Lorem ipsum dolor sit (UF)

08:40 - 08:55:
CESM for breast cancer screening, what is the best place for it?

Speaker: Lorem ipsum dolor sit (UF)

08:55 - 09:05:
Discussion

09:05 - 09:10

Sponsor`s Video.

09:10 - 10:25

BREAST CANCER SCREENING – ROUND 02

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

09:10 – 09:15:
Presentation

09:15 – 09:30:
Breast Cancer Screening Trials Endpoints and Overdiagnosis

Speaker: Lorem ipsum dolor sit (UF)

09:30 – 09:45:
RMI or CESM for Breast Cancer Staging, which case it should be standard indicated?

Speaker: Lorem ipsum dolor sit (UF)

09:45 – 10:00:
CESM second look and guided biopsy.

Speaker: Lorem ipsum dolor sit (UF)

10:00 – 10:07:
Presentation of oral abstracts selected

Speaker: Lorem ipsum dolor sit (UF)

10:07 – 10:14:
Presentation of oral abstracts selected

Speaker: Lorem ipsum dolor sit (UF)

10:14 - 10:25:
Discussion

10:25 – 10:30

Sponsor`s Video.

10:30 - 11:30

B3 LESIONS AND PERCUTANEOUS PROCEDURES - ROUND 1

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

10:30 –10:35:
Presentation

10:35 – 10:50:
Surgery x Vacuum Assisted Excision (VAE) for B3 lesions on core biopsy, how to do you choose it?

Speaker: Lorem ipsum dolor sit (UF)

10:50 – 11:05:
Vacuum assisted excision and a pathological report of ductal atypia, is there any role for MRI?

Speaker: Lorem ipsum dolor sit (UF)

11:05 – 11:20:
What skills are requested for Vacuum assisted excision, what are the complications and how to deal with?

Speaker: Lorem ipsum dolor sit (UF)

11:20 – 11:30:
Discussion

11:30 - 12:15

BREAST CANCER SCREENING STATE OF ART

11:30 – 12:00:
Educational abstract selected

Speaker: Lorem ipsum dolor sit (UF)

12:00 – 12:15:
Discussion

13:15 - 14:15

DE-ESCALATION FOR DCIS.

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

13:15 – 13:20:
Presentation

13:20 – 13:35:
How to assure that it is truly low risk pathological DCIS?

Speaker: Lorem ipsum dolor sit (UF)

13:35 – 13:50:
De-escalating treatment of low-risk DCIS what should I choose to omit? Surgery x Endocrine therapy x Radiotheraphy x none?

Speaker: Lorem ipsum dolor sit (UF)

13:50 – 14:05:
How long is safe to wait to start DCIS treatment?

Speaker: Lorem ipsum dolor sit (UF)

14:05 – 14:15:
Discussion

14:15 – 15:20

Sponsor`s Video.

14:20 – 15:20

SPONSOR`S SYMPOSIUM

15:20 – 15:25

Sponsor`s Video.

15:25 – 16:25

DE -ESCALATING TREATMENT OF INVASIVE CANCER – ROND 01

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

15:25 – 15:30:
Presentation

15:30 – 15:45:
The role of RMI in selecting cases for percutaneous treatment of breast cancer.

Speaker: Lorem ipsum dolor sit (UF)

15:45 – 16:00:
Is it possible to predict complete resection of small breast cancers by vacuum assisted excision associated with percutaneous sampling (´´shaving``) of cavity margins? Prelimary results of our retrospective series.

Speaker: Lorem ipsum dolor sit (UF)

16:00 - 16:15:
Selection criteria for Vacuum Assisted Excision for Small Breast Cancers.

Speaker: Lorem ipsum dolor sit (UF)

16:15 – 16:25:
Discussion

16:25 – 16:30

Sponsor`s Video.

16:30 - 17:30

DE-ESCALATING RADIOTHERAPHY – ROUND 01

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

16:30 – 16:35:
Presentation

16:35 – 16:50:
Omitting RTx based on MRI

Speaker: Lorem ipsum dolor sit (UF)

16:50 – 17:05:
Five days radiotherapy x intraoperative radiotherapy – What is the best choice for de-escalation?

Speaker: Lorem ipsum dolor sit (UF)

17:05 – 17:20:
Intraoperative Radiotherapy approaches, is there some to choose?

Speaker: Lorem ipsum dolor sit (UF)

17:20 - 17:30:
Discussion

17:30 - 18:30

TUMOR BOARD DISCUSSION. REAL LIFE CASES FOR DE-ESCALATION

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

17:30 – 17:35:
Presentation

Speaker: Lorem ipsum dolor sit

17:35 – 17:50:
Axillary observation alone: up front scenario.

Speaker: Lorem ipsum dolor sit (UF)

17:50 – 18:05:
Axillary biopsy in early breast cancer: does it lead to overtreatment?

Speaker: Darío M Schejtman (Argentina)

18:05 – 18:30:
Discussion

18:30 - 19:00

DE-ESCALATING LUMINAL BREAST CANCER TREATMENT IN WOMAN OLDER THAN 60 YEARS – STATE OF ART

18:30 – 18:45:
Educational abstract selected

Speaker: Lorem ipsum dolor sit (UF)

18:45 – 19:00:
Discussion

08:00 - 08:05

OPENING

Lorem ipsum dolor sit (UF)


Lorem ipsum dolor sit (UF)


Lorem ipsum dolor sit (UF)

08:05 - 09:05

DE -ESCALATING AXILLAR SURGERY

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

08:05 – 08:10:
Presentation

08:10 - 08:25:
Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c/iT1-2) in the Context of Breast Conserving Therapy

Speaker: Lorem ipsum dolor sit (UF)

08:25 - 08:40:
One to two not palpable but imaging and histologically positive axillary nodes. Up front surgery x Neoadjuvant Systemic Treatment

Speaker: Lorem ipsum dolor sit (UF)

08:40 – 08:47:
Presentation of oral abstracts selected

Speaker: Lorem ipsum dolor sit (UF)

08:47 - 08:54:
Discussion

08:54 - 09:05:
Discussion

09:05 - 09:10

Sponsor`s Video.

09:10 - 10:10

SPONSOR`S SYMPOSIUM

10:10 - 11:00

-----

Coordinator: Lorem ipsum dolor sit (UF)

Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)


Debater: Lorem ipsum dolor sit (UF)

10:10 - 10:15:
Presentation

10:15 – 10:35:
For Safety Omitting Surgery after NST what is needed?

Speaker: Lorem ipsum dolor sit (UF)

10:35 – 10:50:
Axillary Omission of radical axillary surgery after positive sentinel biopsy after NST, is it already in course in clinical practice?

Speaker: Lorem ipsum dolor sit (UF)

10:50 – 11:00:
Discussion

11:00 – 11:05

Sponsor`s Video.

11:05 - 11:35

DE-ESCALATING LUMINAL BREAST CANCER TREATMENT IN WOMAN OLDER THAN 60 YEARS – STATE OF ART

11:05 – 11:20:
Educational abstract selected

Speaker: Lorem ipsum dolor sit (UF)

11:20 – 11:35:
Discussion

11:35 - 12:05

MASTER CLASS

The challenges of de-escalating treatment in breast cancer (patient/clinician acceptability; risks of de-escalating one treatment modality but escalating others e.g. surgery vs RT; challenges of study design – non-inferiority RCT vs cohort studies etc etc)

Speaker: Lorem ipsum dolor sit (UF)

12:05 – 12:15

ENDING

LOCAL DO EVENTO

CENTRO DE CONVENÇÕES DA ASSOCIAÇÃO MÉDICA DE MINAS GERAIS

Avenida João Pinheiro, 161, Centro

Belo Horizonte – MG

Como chegar

DON'T MISS THE OPPORTUNITY Make your registration

SIGN UP FOR OUR NEWSLETTER

RECEIVE IN YOUR EMAIL ALL THE NEWS ABOUT THE EVENT

CIRURGIAS COMENTADAS POR Superespecialistas

REALIZATION

DIAMOND SPONSORSHIP

GOLD SPONSORSHIP

SILVER SPONSORSHIP

BRONZE SPONSORSHIP

SPONSORSHIP

SUPPORT

BreastMit 2022 | 3rd International Symposium on Minimal Treatment and Breast Imaging

Dev by